From immunostaining of the tumor areas in the brain sections, we found that both SON expression and PTBP1 expression levels are significantly downregulated in tumors formed by SON shRNA-expressing GSCs (Fig. 8c, d), consistent with our in vitro data. Here, PTBP1 is linked to neoplasm.